FDA Adverse Event
Injury
Summary report: N
TELIGEN
MDR report key: 3040736
·
Received April 8, 2013
Report
- Report Number
- 2124215-2013-03114
- Event Type
- Injury
- Date Received
- April 8, 2013
- Date of Event
- January 2, 2013
- Report Date
- January 3, 2013
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC
- Reporter Occupation
- PATIENT
Narratives
Additional Manufacturer Narrative · 1
THIS REPORT WILL BE UPDATED SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) HAD A SYNCOPAL EPISODE. THERE WAS NO ADDITIONAL INFORMATION PROVIDED AT THE TIME OF THE CALL. A REQUEST FOR ADDITIONAL INFORMATION HAS BEEN SENT TO THE LOCAL FIELD REPRESENTATIVE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 144041 | TELIGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | E110 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 43 YR | Life Threatening| R | 0184| 4086| T165| E110 |